- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Lalan Wilfong on the Struggle for Reimbursement of Novel Cancer Therapies
"The cost of cancer care is rising dramatically," said Lalan Wilfong, MD, executive vice president of quality programs at Texas Oncology.
"The cost of cancer care is rising dramatically," said Lalan Wilfong, MD, executive vice president of quality programs at Texas Oncology.
What is the struggle for reimbursement for new innovative cancer therapies?Transcript:
So, cost of cancer care is rising dramatically, and the cost of new innovative cancer therapies is quite high— there are many reasons behind that– but the cost of care is quite high. It’s difficult to address that in a practice because we don’t control the cost of care. You want to provide the appropriate care for the appropriate patient at the appropriate time– that’s the mantra for taking good care of patients.
It’s a difficult question to figure out how do we address that in the care that we provide. I think pathways is one way to do that where we can look at what an appropriate, new, innovative therapy is and which patient population they should be given to. Doing innovative payment adjustments is also important so the practices aren’t discouraged from using novel therapies where they are appropriate. I think the challenge is figuring out which novel therapies are appropriate for which patients and making sure you’re utilizing them appropriately for the patients that you have.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Implementation, Adherence to DoxyPEP Remains Low in At-Risk Groups
March 12th 2025Patients in Washington D.C. and San Francisco had minimal early uptake and adherence to doxycycline post-exposure prophylaxis (DoxyPEP) in studies presented at the Conference on Retroviruses and Opportunistic Infections 2025.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
